Artios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215 28 September 2021 | Press release
Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications 17 June 2021 | Press release